TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Mammography Screening For Ages 40-49 Not Supported By Data, NIH Pane! Says January 31, 1997